Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Eaves, AC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Uchida, N; Fujisaki, T; Eaves, AC; Eaves, CJ
      Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP) phenotype

      JOURNAL OF CLINICAL INVESTIGATION
    2. Holyoake, TL; Jiang, XY; Jorgensen, HG; Graham, S; Alcorn, MJ; Laird, C; Eaves, AC; Eaves, CJ
      Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3

      BLOOD
    3. Holyoake, TL; Horrocks, C; Thomas, T; Eaves, CJ; Eaves, AC
      Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice

      CYTOTHERAPY
    4. Eaves, AC
      President's end-of-the-year report

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    5. Hogge, DE; Lambie, K; Sutherland, HJ; Benny, WB; Dalal, B; Currie, C; Barnett, MJ; Eaves, AC; Eaves, CJ
      Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant

      BONE MARROW TRANSPLANTATION
    6. Brummendorf, TH; Holyoake, TL; Rufer, N; Barnett, MJ; Schulzer, M; Eaves, CJ; Eaves, AC; Lansdorp, PM
      Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

      BLOOD
    7. Cashman, JD; Clark-Lewis, I; Eaves, AC; Eaves, CJ
      Differentiation stage-specific regulation of primitive human hematopoieticprogenitor cycling by exogenous and endogenous inhibitors in an in vivo model

      BLOOD
    8. BRUMMENDORF TH; HOLYOAKE TL; RULER N; DRAGOWSKA W; CHAVEZ E; BARNETT M; MCCAUL K; EAVES CJ; EAVES AC; LANSDORP PM
      TELOMERE LENGTH IN NORMAL AND MALIGNANT-CELLS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA MEASURED BY FLOW-CYTOMETRY

      Experimental hematology
    9. CASHMAN JD; EAVES CJ; SARRIS AH; EAVES AC
      MCP-1, NOT MIP-1-ALPHA, IS THE ENDOGENOUS CHEMOKINE THAT COOPERATES WITH TGF-BETA TO INHIBIT THE CYCLING OF PRIMITIVE NORMAL BUT NOT LEUKEMIC (CML) PROGENITORS IN LONG-TERM HUMAN MARROW CULTURES

      Blood
    10. WANG JCY; LAPIDOT T; CASHMAN JD; DOEDENS M; ADDY L; SUTHERLAND DR; NAYAR R; LARAYA P; MINDEN M; KEATING A; EAVES AC; EAVES CJ; DICK JE
      HIGH-LEVEL ENGRAFTMENT OF NOD SCID MICE BY PRIMITIVE NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS FROM PATIENTS WITH CHRONIC MYELOID-LEUKEMIA INCHRONIC PHASE/

      Blood
    11. SHPALL EJ; CHAMPLIN RE; EAVES AC; GEE AP; COLLINS N; LEMAISTRE CF; OREILLY R; ROWLEY SD; SULLIVAN K; VAUGHAN WP; WARKENTIN PL
      FOUNDATION FOR THE ACCREDITATION OF HEMATOPOIETIC-CELL THERAPY (FAHCT) RESPONSE TO FDA (DOCKET NO.97N-0068)

      Journal of hematotherapy
    12. EAVES CJ; EAVES AC
      STEM-CELL KINETICS

      Bailliere's clinical haematology
    13. EAVES CJ; CASHMAN JD; PONCHIO L; EAVES AC
      INTERACTIONS BETWEEN PRIMITIVE HEMATOPOIETIC-CELLS AND BONE-MARROW STROMA

      Experimental hematology
    14. CASHMAN JD; EAVES AC; EAVES CJ
      SELECTIVE-INHIBITION OF THE CYCLING ACTIVITY OF INTERMEDIATE TYPES OFHUMAN PROGENITORS REGENERATED IN NOD SCID MICE/

      Experimental hematology
    15. CASHMAN J; BOCKHOLD K; HOGGE DE; EAVES AC; EAVES CJ
      SUSTAINED PROLIFERATION, MULTI-LINEAGE DIFFERENTIATION AND MAINTENANCE OF PRIMITIVE HUMAN HEMATOPOIETIC-CELLS IN NOD SCID MICE TRANSPLANTEDWITH HUMAN CORD-BLOOD/

      British Journal of Haematology
    16. GHAFFARI S; DOUGHERTY GJ; EAVES AC; EAVES CJ
      DIVERSE EFFECTS OF ANTI-CD44 ANTIBODIES ON THE STROMAL CELL-MEDIATED SUPPORT OF NORMAL BUT NOT LEUKEMIC (CML) HEMATOPOIESIS IN-VITRO

      British Journal of Haematology
    17. PETZER AL; EAVES CJ; BARNETT MJ; EAVES AC
      SELECTIVE EXPANSION OF PRIMITIVE NORMAL HEMATOPOIETIC-CELLS IN CYTOKINE-SUPPLEMENTED CULTURES OF PURIFIED CELLS FROM PATIENTS WITH CHRONIC MYELOID-LEUKEMIA

      Blood
    18. EAVES AC; MCMULLAN JA; VANZEE J; BROUGHTON KS
      DIETARY-FAT MODIFICATION OF SPLEEN IMMUNE CELL PHOSPHOLIPIDS

      The FASEB journal
    19. GHAFFARI S; DOUGHERTY GJ; EAVES AC; EAVES CJ
      ALTERED PATTERNS OF CD44 EPITOPE EXPRESSION IN HUMAN CHRONIC AND ACUTE MYELOID-LEUKEMIA

      Leukemia
    20. PETZER AL; EAVES AC; EAVES CJ
      DECLINE OF CML (PH(-) LTC-IC UNDER CULTURE CONDITIONS THAT STIMULATE EXPANSION OF COEXISTING NORMAL (PH(-)) LTC-IC()) CD34(++)CD38()

      Experimental hematology
    21. PETZER AL; EAVES CJ; LANSDORP PM; PONCHIO L; BARNETT MJ; EAVES AC
      CHARACTERIZATION OF PRIMITIVE SUBPOPULATIONS OF NORMAL AND LEUKEMIC-CELLS PRESENT IN THE BLOOD OF PATIENTS WITH NEWLY-DIAGNOSED AS WELL AS ESTABLISHED CHRONIC MYELOID-LEUKEMIA

      Blood
    22. MAGUERSATTA V; PETZER AL; EAVES AC; EAVES CJ
      BCR-ABL EXPRESSION IN DIFFERENT SUBPOPULATIONS OF FUNCTIONALLY CHARACTERIZED PH(-LEUKEMIA() CD34(+) CELLS FROM PATIENTS WITH CHRONIC MYELOID)

      Blood
    23. PETZER AL; LANSDORP PM; SHAW GJ; BARNETT MJ; EAVES AC; EAVES CJ
      ELEVATED NUMBERS OF CD38(-), THY-1(-IC ARE PRESENT IN THE BLOOD OF NEWLY-DIAGNOSED CML PATIENTS AND INCLUDE BOTH PH(-) AND PH(+) GENOTYPES() LTC)

      Experimental hematology
    24. GHAFFARI S; DOUGHERTY GJ; LANSDORP PM; EAVES AC; EAVES CJ
      DIFFERENTIATION - ASSOCIATED CHANGES IN CD44 ISOFORM EXPRESSION DURING NORMAL HEMATOPOIESIS AND THEIR ALTERATION IN CHRONIC MYELOID-LEUKEMIA

      Blood
    25. VARGA MER; EAVES CJ; PIRET JM; EAVES AC
      POTENTIAL USE OF STIRRED SUSPENSION BIOREACTORS FOR THE MANIPULATION OF CML AUTOGRAFTS

      Blood
    26. WANG JCY; LAPIDOT T; CASHMAN JD; SIRARD C; DOEDENS M; LARAYA P; ADDY L; MINDEN M; KEATING A; EAVES AC; EAVES CJ; DICK JE
      ENGRAFTMENT OF PRIMITIVE NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS FROMCHRONIC PHASE CML PATIENTS IN IMMUNODEFICIENT MICE

      Blood
    27. PETZER AL; EAVES AC; EAVES CJ
      RAPID LOSS OF THE DEFINING ATTRIBUTES OF CML LTC-IC IN CULTURES OF PH(-) CELLS MAINTAINED IN SERUM-FREE CYTOKINE-SUPPLEMENTED MEDIUM UNDER CONDITIONS THAT STIMULATE EXTENSIVE AMPLIFICATION OF NORMAL LTC-IC() CD34(+)CD38()

      Blood
    28. KLINGEMANN HG; EAVES CJ; BARNETT MJ; EAVES AC; HOGGE DE; NANTEL SH; REECE E; SHEPHERD JD; SUTHERLAND HJ; PHILLIPS GL
      TRANSPLANTATION OF PATIENTS WITH HIGH-RISK ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION WITH AUTOLOGOUS MARROW CULTURED IN INTERLEUKIN-2 FOLLOWED BY INTERLEUKIN-2 ADMINISTRATION

      Bone marrow transplantation
    29. CASHMAN JD; EAVES AC; EAVES CJ
      THE TETRAPEPTIDE ACSDKP SPECIFICALLY BLOCKS THE CYCLING OF PRIMITIVE NORMAL BUT NOT LEUKEMIC PROGENITORS IN LONG-TERM CULTURE - EVIDENCE FOR AN INDIRECT MECHANISM

      Blood
    30. BARNETT MJ; EAVES CJ; PHILLIPS GL; GASCOYNE RD; HOGGE DE; HORSMAN DE; HUMPHRIES RK; KLINGEMANN HG; LANSDORP PM; NANTEL SH; REECE DE; SHEPHERD JD; SPINELLI JJ; SUTHERLAND HJ; EAVES AC
      AUTOGRAFTING WITH CULTURED MARROW IN CHRONIC MYELOID-LEUKEMIA - RESULTS OF A PILOT-STUDY

      Blood
    31. BARNETT MJ; EAVES CJ; PHILLIPS GL; HOGGE DE; KLINGEMANN HG; LANSDORP PM; NANTEL SH; REECE DE; SHEPHERD JD; SUTHERLAND HJ; EAVES AC
      AUTOGRAFTING IN CHRONIC MYELOID-LEUKEMIA WITH CULTURED MARROW - UPDATE OF THE VANCOUVER STUDY

      Stem cells
    32. EAVES CJ; CASHMAN JD; ZOUMBOS NC; BARNETT MJ; EAVES AC
      BIOLOGICAL STRATEGIES FOR THE SELECTIVE MANIPULATION OF NORMAL AND LEUKEMIC STEM-CELLS

      Stem cells
    33. EAVES AC; EAVES CJ; PHILLIPS GL; BARNETT MJ
      CULTURE PURGING IN LEUKEMIA - PAST, PRESENT, AND FUTURE

      Leukemia & lymphoma
    34. EAVES CJ; BARNETT MJ; EAVES AC
      IN-VITRO CULTURE OF BONE-MARROW CELLS FOR AUTOGRAFTING IN CML

      Leukemia
    35. KLINGEMANN HG; EAVES CJ; BARNETT MJ; EAVES AC; HOGGE DE; LANSDORP PH; NANTEL SH; REECE DE; SHEPHERD JD; SUTHERLAND HJ; PHILLIPS GL
      TRANSPLANTATION OF PATIENTS WITH HIGH-RISK ACUTE MYELOID-LEUKEMIA (AML) IN FIRST REMISSION WITH AUTOLOGOUS MARROW CULTURED IN INTERLEUKIN-2FOLLOWED BY INTERLEUKIN-2 IN-VIVO

      Experimental hematology
    36. ZOUMBOS N; EAVES N; BARNETT CJ; EAVES AC
      SELECTIVE INHIBITORY EFFECT OF INTERFERON-ALPHA (IFN-ALPHA) IN-VITRO ON NEOPLASTIC LONG-TERM CULTURE-INITIATING CELLS (LTC-IC) FROM PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML)

      Experimental hematology
    37. EAVES CJ; CASHMAN JD; WOLPE SD; EAVES AC
      UNRESPONSIVENESS OF PRIMITIVE CHRONIC MYELOID-LEUKEMIA CELLS TO MACROPHAGE INFLAMMATORY PROTEIN 1-ALPHA, AN INHIBITOR OF PRIMITIVE NORMAL HEMATOPOIETIC-CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    38. CASHMAN JD; EAVES AC; EAVES CJ
      EVIDENCE THAT ACSDKP CAN BLOCK THE CYCLING OF PRIMITIVE NORMAL BUT NOT LEUKEMIC PROGENITORS BY AN INDIRECT MECHANISM INVOLVING MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA

      Blood
    39. SHEPHERD JD; CURRIE CJ; SPARLING TG; KRYSTAL G; EAVES AC
      ERYTHROPOIETIN THERAPY OF MYELODYSPLASTIC SYNDROMES

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:19:00